MingCeler Biotechnology Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Series A
- Investors
-
5
MingCeler Biotechnology General Information
Description
Provider of biotech laboratory services designed for animal model technology. The company utilizes tetraploid compensation and gene editing technologies, providing biotechnology institutions and pharmaceutical companies with customized mouse models to conduct biological research.
Contact Information
Website
www.mingceler.comCorporate Office
- Room 601, Building 13
- Number. 188 Kaiyuan Avenue, Huangpu District
- Guangzhou, Guangdong 510000
- China
Corporate Office
- Room 601, Building 13
- Number. 188 Kaiyuan Avenue, Huangpu District
- Guangzhou, Guangdong 510000
- China
MingCeler Biotechnology Timeline
MingCeler Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 13-Jul-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 15-Jul-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 30-Jun-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 13-Sep-2022 | $1.45M | $1.45M | Completed | Startup | |
| 1. Seed Round | Completed | Startup |
MingCeler Biotechnology Patents
MingCeler Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026098510-A1 | Construction method for quadruple-resistant animal and use thereof | Pending | 11-Nov-2024 | ||
| EP-4144857-A1 | Animal preparation method | Pending | 06-Mar-2020 | ||
| EP-4144857-A4 | Animal preparation method | Pending | 06-Mar-2020 | ||
| US-20240263194-A1 | Animal preparation method | Pending | 06-Mar-2020 | ||
| JP-2023516767-A | Animal production method | Active | 06-Mar-2020 | C12N15/8775 |
MingCeler Biotechnology Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shaanxi Kekong Xietong Venture Capital | Growth/Expansion | Minority | ||
| Elevation China Capital | Venture Capital | Minority | ||
| Guangzhou Jinkong Fund | Asset Manager | Minority | ||
| Entropy Capital | Asset Manager | Minority | ||
| Hunan Shangyi Guanxi Asset Management | PE/Buyout | Minority |
MingCeler Biotechnology FAQs
-
When was MingCeler Biotechnology founded?
MingCeler Biotechnology was founded in 2022.
-
Where is MingCeler Biotechnology headquartered?
MingCeler Biotechnology is headquartered in Guangzhou, China.
-
What industry is MingCeler Biotechnology in?
MingCeler Biotechnology’s primary industry is Laboratory Services (Healthcare).
-
Is MingCeler Biotechnology a private or public company?
MingCeler Biotechnology is a Private company.
-
What is MingCeler Biotechnology’s current revenue?
The current revenue for MingCeler Biotechnology is .
-
How much funding has MingCeler Biotechnology raised over time?
MingCeler Biotechnology has raised $4.23M.
-
Who are MingCeler Biotechnology’s investors?
Shaanxi Kekong Xietong Venture Capital, Elevation China Capital, Guangzhou Jinkong Fund, Entropy Capital, and Hunan Shangyi Guanxi Asset Management have invested in MingCeler Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process